Untitled-design-107
FAQ's
Answer : According to Precedence Research, the global lyme disease diagnostic devices market size was valued at USD 2.03 billion in 2019 and is predicted to surpass around USD 3.87 billion by the end of 2027.
Answer : The global lyme disease diagnostic devices market is expected to grow at a CAGR of 7.2% during the forecast period 2020 to 2027.
Answer : Among the product type segment, serological test dominated the overall market. High use of serological testing in the detection of Lyme disease is the major reason for high market share of serological tests.
Answer : The hospitals accounted for the largest revenue with more than 61% share in 2019. High incidence of Lyme disease and increasing demand for early detection are the major reasons for high market share of hospital.
Answer : North America dominated the global market with a market share of more than 36%.
Answer : Asia Pacific is anticipated to grow at the maximum CAGR of around 8.2% in the forecast period due to high incidence of chronic disorders.
Answer : The major companies functioning in the worldwide Lyme disease diagnostic devices market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Boulder Diagnostics, T2 Biosystems, Inc., Abbott, Oxford Immunotec Global PLC, Quidel Corporation, Affymetrix Inc., F. Hoffmann-La Roche Ltd, and Graphene Frontiers among others.
Get a Sample of this Report
Untitled-design-107
